What is the management approach for a partially empty sella (partial empty sella turcica)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: July 28, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Management of Partially Empty Sella

MRI is the preferred diagnostic imaging modality for evaluation and management of partially empty sella, with endocrinologic assessment recommended for all patients to evaluate for potential hormone deficiencies.

Diagnostic Approach

Imaging

  • MRI with high-resolution pituitary protocol is the gold standard for diagnosis and characterization of empty sella 1

    • Well characterized even without IV contrast
    • Provides detailed visualization of pituitary gland flattening against sellar floor
    • Allows assessment of pituitary stalk and optic chiasm
    • Can detect herniation of subarachnoid space into sella turcica
  • CT scan may be used if MRI is contraindicated 1

    • Less sensitive than MRI for detecting pituitary abnormalities
    • Useful for evaluating bony structures of the sella

Clinical and Endocrinologic Evaluation

  • Comprehensive hormonal assessment is essential as up to 40% of patients may have at least one hormone deficiency 2

    • Growth hormone
    • Thyroid function
    • Adrenal function
    • Gonadal hormones
    • Prolactin
  • Ophthalmologic evaluation if visual symptoms are present 3

    • Visual field testing
    • Visual acuity assessment

Management Algorithm

1. Asymptomatic Patients with Normal Hormone Function

  • Observation with periodic follow-up
  • Hormonal reassessment at 24-36 months due to low risk of progression 2
  • No specific treatment required

2. Patients with Hormone Deficiencies

  • Hormone replacement therapy based on specific deficiencies 4, 5
    • Levothyroxine for hypothyroidism
    • Cortisone acetate for hypoadrenalism
    • Growth hormone replacement if deficient
    • Sex hormone replacement if hypogonadism present

3. Patients with Visual Disturbances

  • Surgical intervention may be considered in cases of progressive visual field defects 6
    • Endoscopic transsphenoidal approach
    • Sellar elevation using implants (e.g., silastic coil)
    • Goal is to relieve pressure on optic structures

4. Patients with CSF Rhinorrhea

  • Surgical repair of the defect in the sellar diaphragm 5
    • Transsphenoidal approach
    • Closure of CSF leak

Special Considerations

Primary vs. Secondary Empty Sella

  • Primary empty sella: Idiopathic, often associated with:

    • Obesity
    • Hypertension
    • Female sex
    • Multiparity
    • Possible association with idiopathic intracranial hypertension 5
  • Secondary empty sella: Requires management of underlying cause 5

    • Post-surgical
    • Post-radiation
    • After pituitary apoplexy
    • Following treatment of pituitary tumors

Monitoring and Follow-up

  • Regular endocrine assessment to detect development of new hormone deficiencies
  • Periodic imaging (typically every 2-3 years) to monitor for any changes 2
  • Visual field testing if visual symptoms develop

Clinical Pitfalls to Avoid

  • Assuming all empty sella cases are benign incidental findings - up to 30% of patients may have hypopituitarism requiring treatment 1
  • Missing the association with idiopathic intracranial hypertension - evaluate for headaches and papilledema
  • Failure to distinguish between primary and secondary empty sella - management differs based on etiology
  • Overlooking subtle hormone deficiencies - comprehensive testing is essential even in apparently asymptomatic patients

Empty sella syndrome represents a heterogeneous clinical entity requiring a multidisciplinary approach involving endocrinology, neurology, and ophthalmology for optimal management 5.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Empty sella syndrome: an update.

Pituitary, 2024

Research

Empty sella syndrome.

Pediatric endocrinology reviews : PER, 2012

Research

Asymptomatic Empty Sella Syndrome: A "New" Hypothalamic Pathology or Paraphysiological Variant.

Endocrine, metabolic & immune disorders drug targets, 2024

Research

Empty sella syndrome: Multiple endocrine disorders.

Handbook of clinical neurology, 2021

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.